# Biolinq funding rounds and investors

As of 14 Oct 2026, Biolinq has raised $100M across 1 verified round on record; latest: $100 million Series C led by Alpha Wave, announced 22 Apr 2025.

Biolinq sells wearable biosensor technology that monitors glucose levels for health and metabolic insights.

Website: https://www.biolinq.com  
Page: https://fireround.dev/companies/biolinq.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2025-04-22 | Series C | $100 million | Alpha Wave | Aphelion Capital, AXA IM Alts, Features Capital, Hikma Ventures, LifeSci Venture Partners, M Ventures, RiverVest Venture Partners, Taisho Pharmaceutical | [biolinq.com](https://www.biolinq.com/news/biolinq-announces-close-of-100m-series-c-financing-to-advance-its-biowearable-platform-for-metabolic-health) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.